Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Epidemiology of venous thromboembolism.

Heit JA.

Nat Rev Cardiol. 2015 Aug;12(8):464-74. doi: 10.1038/nrcardio.2015.83. Epub 2015 Jun 16. Review.

2.

Evaluation of chromosomal abnormalities and common trombophilic mutations in cases with recurrent miscarriage.

Karatas A, Eroz R, Albayrak M, Ozlu T, Cakmak B, Keskin F.

Afr Health Sci. 2014 Mar;14(1):216-22. doi: 10.4314/ahs.v14i1.34.

3.

Prevalence of thrombophilia in asymptomatic individuals with a family history of thrombosis.

Vagdatli E, Serafimidou O, Pantziarela E, Tsikopoulou F, Mitsopoulou K, Papoutsi A.

Hippokratia. 2013 Oct;17(4):359-62.

4.

Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants.

Nakashima MO, Rogers HJ.

Blood Res. 2014 Jun;49(2):85-94. doi: 10.5045/br.2014.49.2.85. Epub 2014 Jun 25. Review.

5.

Hereditary thrombophilic risk factors for recurrent pregnancy loss.

Bogdanova N, Markoff A.

J Community Genet. 2010 Jun;1(2):47-53. doi: 10.1007/s12687-010-0011-3. Epub 2010 Jun 11.

6.

Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network.

Fullerton SM, Wolf WA, Brothers KB, Clayton EW, Crawford DC, Denny JC, Greenland P, Koenig BA, Leppig KA, Lindor NM, McCarty CA, McGuire AL, McPeek Hinz ER, Mirel DB, Ramos EM, Ritchie MD, Smith ME, Waudby CJ, Burke W, Jarvik GP.

Genet Med. 2012 Apr;14(4):424-31. doi: 10.1038/gim.2012.15. Epub 2012 Feb 23.

7.

CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies.

Johnson AD, Bhimavarapu A, Benjamin EJ, Fox C, Levy D, Jarvik GP, O'Donnell CJ.

Genet Med. 2010 Jun;12(6):355-63. doi: 10.1097/GIM.0b013e3181e1e2a9.

8.

Usefulness of factor V Leiden mutation testing in clinical practice.

Blinkenberg EØ, Kristoffersen AH, Sandberg S, Steen VM, Houge G.

Eur J Hum Genet. 2010 Aug;18(8):862-6. doi: 10.1038/ejhg.2010.33. Epub 2010 Mar 24.

9.

Use of Factor V Leiden genetic testing in practice and impact on management.

Laberge AM, Psaty BM, Hindorff LA, Burke W.

Genet Med. 2009 Oct;11(10):750-6. doi: 10.1097/GIM.0b013e3181b3a697.

10.

Motivating factors for physician ordering of factor V Leiden genetic tests.

Hindorff LA, Burke W, Laberge AM, Rice KM, Lumley T, Leppig K, Rosendaal FR, Larson EB, Psaty BM.

Arch Intern Med. 2009 Jan 12;169(1):68-74. doi: 10.1001/archinternmed.2008.517.

11.

Left sided inferior vena cava duplication and venous thromboembolism: case report and review of literature.

Milani C, Constantinou M, Berz D, Butera JN, Colvin GA.

J Hematol Oncol. 2008 Dec 2;1:24. doi: 10.1186/1756-8722-1-24.

12.

Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis.

Goddard KA, Robitaille J, Dowling NF, Parrado AR, Fishman J, Bradley LA, Moore CA, Khoury MJ.

Public Health Genomics. 2009;12(2):92-104. doi: 10.1159/000176794. Epub 2008 Nov 26.

13.

Testing for hereditary thrombophilia: a retrospective analysis of testing referred to a national laboratory.

Jackson BR, Holmes K, Phansalkar A, Rodgers GM.

BMC Clin Pathol. 2008 Apr 2;8:3. doi: 10.1186/1472-6890-8-3.

14.

Hereditary thrombophilia.

Khan S, Dickerman JD.

Thromb J. 2006 Sep 12;4:15.

Items per page

Supplemental Content

Write to the Help Desk